| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.5 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.5 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |